476 related articles for article (PubMed ID: 19393208)
1. Proteomic toolbox for autoimmunity research.
Wu T; Mohan C
Autoimmun Rev; 2009 Jun; 8(7):595-8. PubMed ID: 19393208
[TBL] [Abstract][Full Text] [Related]
2. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
3. The Lucid Proteomics System for top-down biomarker research.
Jourdain S; Bulman A; Dalmasso E
Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
[TBL] [Abstract][Full Text] [Related]
4. The role of electrophoresis in disease biomarker discovery.
Issaq HJ; Veenstra TD
Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
[TBL] [Abstract][Full Text] [Related]
5. Proteomic approaches for serum biomarker discovery in cancer.
Maurya P; Meleady P; Dowling P; Clynes M
Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
[TBL] [Abstract][Full Text] [Related]
6. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
7. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of breast carcinoma.
Somiari RI; Somiari S; Russell S; Shriver CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
10. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
11. Methods of comparative proteomic profiling for disease diagnostics.
Steel LF; Haab BB; Hanash SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
[TBL] [Abstract][Full Text] [Related]
12. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
13. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
Powell DW; Merchant ML; Link AJ
Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
[TBL] [Abstract][Full Text] [Related]
14. The birth and infancy of proteomic analysis in osteoarthritis research.
De Ceuninck F
Curr Opin Mol Ther; 2007 Jun; 9(3):263-9. PubMed ID: 17608025
[TBL] [Abstract][Full Text] [Related]
15. Proteomics methods and applications for the practicing clinician.
Reisdorph NA; Reisdorph R; Bowler R; Broccardo C
Ann Allergy Asthma Immunol; 2009 Jun; 102(6):523-9. PubMed ID: 19558013
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches.
Thon JN; Schubert P; Duguay M; Serrano K; Lin S; Kast J; Devine DV
Transfusion; 2008 Mar; 48(3):425-35. PubMed ID: 18067510
[TBL] [Abstract][Full Text] [Related]
17. Revealing urologic diseases by proteomic techniques.
Lee SW; Lee KI; Kim JY
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):203-13. PubMed ID: 15652810
[TBL] [Abstract][Full Text] [Related]
18. Proteomic technology and its biomedical applications.
Lau AT; He QY; Chiu JF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric compatibility of Deep Purple and SYPRO Ruby total protein stains for high-throughput proteomics using large-format two-dimensional gel electrophoresis.
Nock CM; Ball MS; White IR; Skehel JM; Bill L; Karuso P
Rapid Commun Mass Spectrom; 2008; 22(6):881-6. PubMed ID: 18293286
[TBL] [Abstract][Full Text] [Related]
20. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Schiffer E; Mischak H; Novak J
Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
